Islet Specific Wnt Activation in Human Type II Diabetes
Figure 5
β-catenin is upregulated in islets from type II diabetic patients.
Insulin (a) and (c) and β-catenin (b) and (d) are inverely expressed in the pancreas of type II diabetic patients (a)–(d). Islets
with weak insulin expression (solid lines) had the highest levels of β-catenin and islets with strong insulin expression
(dashed lines) had levels of β-catenin intermediate between the weak insulin expressing islets and islets from
nondiabetic individuals. Quantitation of β-catenin expression in β-cells from nondiabetic and type II diabetic
individuals with strong (S) and weak (W) insulin staining (e). Insulin staining of weak islets was 3.5-fold less
intense than in islets with strong insulin staining. More than 200 islets were examined (). Amylase (red in (f))
and insulin (green in (g)) colocalized in weak insulin-expressing islets in type II diabetes (solid line) but not in high
insulin expressing islets (dashed line) (merged in (h)). Weak insulin expressing islets (marked with solid lines) retained
PDX-1 expression (red in (i)) but lost γ-catenin ((j) and (k), islet with strong insulin marked with arrowheads). Weak insulin expressing
islets (solid line) contained normal glucagon expressing cells that did not express amylase (l).
Scale bars: 50 m. All images are confocal.